Means and methods for determining risk of type-1 diabetes by serum protein biomarkers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10877034
APP PUB NO 20170160276A1
SERIAL NO

15319515

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods for predicting a risk of a subject for Type 1 diabetes (T1D) on the basis of expression levels of protein markers in a sample obtained from the subject. The present invention also relates to in vitro kits for use in said methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TURUN YLIOPISTOYLIOPISTONMÄKI TURKU 20014

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhosale, Santosh Turku, FI 2 0
Goodlett, David Baltimore, US 5 27
Lähdesmäki, Harri Espoo, FI 3 0
Lahesmaa, Riitta Turku, FI 9 3
Moulder, Robert Turku, FI 2 0
Simell, Olli Raisio, FI 5 12

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 29, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 29, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00